Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cognition Therapeutics In...

    NASDAQ: CGTX · Real-Time Price · USD
    0.30
    0.00 (1.59%)
    At close: Jun 09, 2025, 3:59 PM

    Cognition Therapeutics Statistics

    Share Statistics

    Cognition Therapeutics has 61.99M shares outstanding. The number of shares has increased by 54.71% in one year.

    Shares Outstanding

    n/a
    		 61.99M

    Shares Change (YoY)

    n/a
    		 54.71%

    Shares Change (QoQ)

    n/a
    		 49.16%

    Owned by Institutions (%)

    n/a
    		 27.39%

    Shares Floating

    n/a
    		 50.25M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,548

    FTD / Avg. Volume

    n/a
    		 0.33%

    Short Selling Information

    The latest short interest is 1.34M, so 2.17% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.34M

    Short % of Shares Out

    n/a
    		 2.17%

    Short % of Float

    n/a
    		 2.41%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.82 and the forward PE ratio is -1.04. Cognition Therapeutics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.82

    Forward PE

    n/a
    		 -1.04

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 1.49

    P/FCF Ratio

    n/a
    		 -0.98

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Cognition Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 2.65

    Quick Ratio

    n/a
    		 2.65

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,358,840

    Employee Count

    n/a
    		 25

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -84.62% in the last 52 weeks. The beta is 0.74, so Cognition Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.74

    52-Week Price Change

    n/a
    		 -84.62%

    50-Day Moving Average

    n/a
    		 0.35

    200-Day Moving Average

    n/a
    		 0.51

    Relative Strength Index (RSI)

    n/a
    		 44.31

    Average Volume (20 Days)

    n/a
    		 1,070,573

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -53.97M

    Net Income

    n/a
    		 -33.97M

    EBITDA

    n/a
    		 -33.68M

    EBIT

    n/a
    		 -34M

    Earnings Per Share (EPS)

    n/a
    		 -0.86
    Full Income Statement

    Balance Sheet

    The company has 25.01M in cash and 814K in debt, giving a net cash position of 24.2M.

    Cash & Cash Equivalents

    n/a
    		 25.01M

    Total Debt

    n/a
    		 814K

    Net Cash

    n/a
    		 24.2M

    Retained Earnings

    n/a
    		 -175.16M

    Total Assets

    n/a
    		 23.5M

    Working Capital

    n/a
    		 11.92M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.47M and capital expenditures -4K, giving a free cash flow of -28.48M.

    Operating Cash Flow

    n/a
    		 -28.47M

    Capital Expenditures

    n/a
    		 -4K

    Free Cash Flow

    n/a
    		 -28.48M

    FCF Per Share

    n/a
    		 -0.72
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CGTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CGTX is $3, which is 900% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 900%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -14.94

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist